XML 69 R57.htm IDEA: XBRL DOCUMENT v3.25.3
REVENUES - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Revenue From Contract With Customer [Line Items]          
Transaction price allocated to remaining performance obligations $ 9,890,000,000   $ 9,890,000,000    
Revenue related to performance obligations 0 $ 0 0 $ 0  
Net trade accounts receivable 1,640,000,000   1,640,000,000   $ 1,540,000,000
Revenue recognized upon satisfaction of performance obligations     89,000,000 $ 94,000,000  
Sales-type lease, net of investment in lease 33,000,000   33,000,000    
2021          
Revenue From Contract With Customer [Line Items]          
Sales-type leases, receivables 3,000,000   3,000,000    
2022          
Revenue From Contract With Customer [Line Items]          
Sales-type leases, receivables 5,000,000   5,000,000    
2023          
Revenue From Contract With Customer [Line Items]          
Sales-type leases, receivables 6,000,000   6,000,000    
2024          
Revenue From Contract With Customer [Line Items]          
Sales-type leases, receivables 10,000,000   10,000,000    
2025          
Revenue From Contract With Customer [Line Items]          
Sales-type leases, receivables $ 9,000,000   $ 9,000,000    
Minimum          
Revenue From Contract With Customer [Line Items]          
Global payment terms     30 days    
Minimum | Software sales          
Revenue From Contract With Customer [Line Items]          
Revenue recognized contract period     1 year    
Minimum | Consumable Medical Products          
Revenue From Contract With Customer [Line Items]          
Revenue recognized contract period     1 year    
Maximum          
Revenue From Contract With Customer [Line Items]          
Global payment terms     90 days    
Maximum | Contract manufacturing services          
Revenue From Contract With Customer [Line Items]          
Revenue recognized contract period     90 days    
Maximum | Software sales          
Revenue From Contract With Customer [Line Items]          
Revenue recognized contract period     5 years    
Maximum | Consumable Medical Products          
Revenue From Contract With Customer [Line Items]          
Revenue recognized contract period     7 years    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-10-01          
Revenue From Contract With Customer [Line Items]          
Remaining revenue performance obligation, percentage of revenue expected to be recognized 5.00%   5.00%    
Remaining performance obligations period 3 months   3 months    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01          
Revenue From Contract With Customer [Line Items]          
Remaining revenue performance obligation, percentage of revenue expected to be recognized 20.00%   20.00%    
Remaining performance obligations period 1 year   1 year    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01          
Revenue From Contract With Customer [Line Items]          
Remaining revenue performance obligation, percentage of revenue expected to be recognized 20.00%   20.00%    
Remaining performance obligations period 1 year   1 year    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2028-01-01          
Revenue From Contract With Customer [Line Items]          
Remaining revenue performance obligation, percentage of revenue expected to be recognized 15.00%   15.00%    
Remaining performance obligations period 1 year   1 year    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2029-01-01          
Revenue From Contract With Customer [Line Items]          
Remaining revenue performance obligation, percentage of revenue expected to be recognized 40.00%   40.00%    
Remaining performance obligations period 1 year   1 year